BioCentury | Aug 18, 2015
Politics & Policy

India allocates $267.8M to improve drug regulation

...hundreds of medicines whose approvals were based primarily on clinical studies conducted by Indian CRO GVK Biosciences Pte. Ltd....
BioCentury | Jun 29, 2015
Company News

Medivir neurology news

...S inhibitor and will focus on cancer and infectious diseases. Medivir also partnered with CRO GVK Biosciences Pte. Ltd....
BioCentury | Jan 24, 2015
Politics & Policy

EMA recommends suspending drugs tested by Indian CRO

...EMA recommended that marketing authorizations be suspended for GVK Biosciences Pte. Ltd. (Hyderabad, India), a CRO. EMA sent its...
BioCentury | Dec 6, 2014
Politics & Policy

EMA halts approval of generics tested at Indian CRO

...suspending approvals of generic drugs whose marketing authorizations were based on bioequivalence studies conducted at GVK Biosciences Pte. Ltd....
BioCentury | Feb 3, 2014
Company News

Aragen Bioscience, GVK Biosciences deal

...presence. The companies did not disclose financial details. Aragen Bioscience Inc. , Morgan Hill, Calif. GVK Biosciences Pte. Ltd....
BioCentury | Feb 4, 2013
Company News

Endo, GVK Biosciences deal

...companies could not be reached for details. Endo Health Solutions Inc. (NASDAQ:ENDP), Chadds Ford, Pa. GVK Biosciences Pte. Ltd....
BioCentury | Jan 14, 2013
Company News

GVK Biosciences, Onconova Therapeutics deal

...retains rights to buy back the programs. The companies could not be reached for details. GVK Biosciences Pte. Ltd....
BioCentury | Dec 5, 2011
Company News

GVK Biosciences, Temple University deal

...CRO GVK Biosciences partnered with the university's Moulder Center for Drug Discovery Research to discover and develop...
...party. The university will own any IP resulting from the deal. Details were not disclosed. GVK Biosciences Pte. Ltd....
BioCentury | Jun 2, 2008
Company News

GVK Biosciences Pte. Ltd., Wyeth deal

...Wyeth Pharmaceuticals division. GVK will receive an undisclosed upfront payment and is eligible for milestones. GVK Biosciences Pte. Ltd....
BioCentury | Feb 25, 2002
Company News

gvk bioSciences Private Ltd., Ricerca LLC, Siegfried Ltd. deal

...Discovery services company Ricerca received exclusive worldwide rights to offer gvk bioSciences’s medicinal chemistry and biology services...
...trials, and Siefried will be responsible for Phase III clinical trial and commercial API manufacturing. gvk bioSciences...
Items per page:
1 - 10 of 10
BioCentury | Aug 18, 2015
Politics & Policy

India allocates $267.8M to improve drug regulation

...hundreds of medicines whose approvals were based primarily on clinical studies conducted by Indian CRO GVK Biosciences Pte. Ltd....
BioCentury | Jun 29, 2015
Company News

Medivir neurology news

...S inhibitor and will focus on cancer and infectious diseases. Medivir also partnered with CRO GVK Biosciences Pte. Ltd....
BioCentury | Jan 24, 2015
Politics & Policy

EMA recommends suspending drugs tested by Indian CRO

...EMA recommended that marketing authorizations be suspended for GVK Biosciences Pte. Ltd. (Hyderabad, India), a CRO. EMA sent its...
BioCentury | Dec 6, 2014
Politics & Policy

EMA halts approval of generics tested at Indian CRO

...suspending approvals of generic drugs whose marketing authorizations were based on bioequivalence studies conducted at GVK Biosciences Pte. Ltd....
BioCentury | Feb 3, 2014
Company News

Aragen Bioscience, GVK Biosciences deal

...presence. The companies did not disclose financial details. Aragen Bioscience Inc. , Morgan Hill, Calif. GVK Biosciences Pte. Ltd....
BioCentury | Feb 4, 2013
Company News

Endo, GVK Biosciences deal

...companies could not be reached for details. Endo Health Solutions Inc. (NASDAQ:ENDP), Chadds Ford, Pa. GVK Biosciences Pte. Ltd....
BioCentury | Jan 14, 2013
Company News

GVK Biosciences, Onconova Therapeutics deal

...retains rights to buy back the programs. The companies could not be reached for details. GVK Biosciences Pte. Ltd....
BioCentury | Dec 5, 2011
Company News

GVK Biosciences, Temple University deal

...CRO GVK Biosciences partnered with the university's Moulder Center for Drug Discovery Research to discover and develop...
...party. The university will own any IP resulting from the deal. Details were not disclosed. GVK Biosciences Pte. Ltd....
BioCentury | Jun 2, 2008
Company News

GVK Biosciences Pte. Ltd., Wyeth deal

...Wyeth Pharmaceuticals division. GVK will receive an undisclosed upfront payment and is eligible for milestones. GVK Biosciences Pte. Ltd....
BioCentury | Feb 25, 2002
Company News

gvk bioSciences Private Ltd., Ricerca LLC, Siegfried Ltd. deal

...Discovery services company Ricerca received exclusive worldwide rights to offer gvk bioSciences’s medicinal chemistry and biology services...
...trials, and Siefried will be responsible for Phase III clinical trial and commercial API manufacturing. gvk bioSciences...
Items per page:
1 - 10 of 10